Federal (United States) · Regulations
Subpart G
24 sections
24 sections
- 21 C.F.R. § 201.300Notice to manufacturers, packers, and distributors of glandular preparations.
- 21 C.F.R. § 201.301Notice to manufacturers, packers, and distributors of estrogenic hormone preparations.
- 21 C.F.R. § 201.302Notice to manufacturers, packers, and distributors of drugs for internal use which contain mineral oil.
- 21 C.F.R. § 201.303Labeling of drug preparations containing significant proportions of wintergreen oil.
- 21 C.F.R. § 201.304Tannic acid and barium enema preparations.
- 21 C.F.R. § 201.305Isoproterenol inhalation preparations (pressurized aerosols, nebulizers, powders) for human use; warnings.
- 21 C.F.R. § 201.306Potassium salt preparations intended for oral ingestion by man.
- 21 C.F.R. § 201.307Sodium phosphates; package size limitation, warnings, and directions for over-the-counter sale.
- 21 C.F.R. § 201.308Ipecac syrup; warnings and directions for use for over-the-counter sale.
- 21 C.F.R. § 201.309Acetophenetidin (phenacetin)-containing preparations; necessary warning statement.
- 21 C.F.R. § 201.310Phenindione; labeling of drug preparations intended for use by man.
- 21 C.F.R. § 201.312Magnesium sulfate heptahydrate; label declaration on drug products.
- 21 C.F.R. § 201.313Estradiol labeling.
- 21 C.F.R. § 201.314Labeling of drug preparations containing salicylates.
- 21 C.F.R. § 201.315Over-the-counter drugs for minor sore throats; suggested warning.
- 21 C.F.R. § 201.316Drugs with thyroid hormone activity for human use; required warning.
- 21 C.F.R. § 201.317Digitalis and related cardiotonic drugs for human use in oral dosage forms; required warning.
- 21 C.F.R. § 201.319Water-soluble gums, hydrophilic gums, and hydrophilic mucilloids (including, but not limited to agar, alginic acid, calcium polycarbophil, carboxymethylcellulose sodium, carrageenan, chondrus, glucomannan ((B-1,4 linked) polymannose acetate), guar gum, karaya gum, kelp, methylcellulose, plantago seed (psyllium), polycarbophil tragacanth, and xanthan gum) as active ingredients; required warnings and directions.
- 21 C.F.R. § 201.320Warning statements for drug products containing or manufactured with chlorofluorocarbons or other ozone-depleting substances.
- 21 C.F.R. § 201.323Aluminum in large and small volume parenterals used in total parenteral nutrition.
- 21 C.F.R. § 201.325Over-the-counter drugs for vaginal contraceptive and spermicide use containing nonoxynol 9 as the active ingredient; required warnings and labeling information.
- 21 C.F.R. § 201.326Over-the-counter drug products containing internal analgesic/antipyretic active ingredients; required warnings and other labeling.
- 21 C.F.R. § 201.327Over-the-counter sunscreen drug products; required labeling based on effectiveness testing.
- 21 C.F.R. § 201.328Labeling of medical gas containers.